Suchergebnisse - "Whyte, Martin"

PubPharm (10)

1

Improved diabetes control, allowing insulin cessation, after direct acting antiviral treatment (DAAT) of hepatitis C

enthalten in: BMJ case reports | 2022

von Surendran, A. | Bhalla, A. | Whyte, M.

2

Mortality Rate Associated with Diabetes : Outcomes From a General Practice Level Analysis in England Using the Royal College of General Practitioners (RCGP) Database Indicate Stability Over a 15 Year Period

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2022

von Heald, A. | Stedman, M. | Robinson, A. | +9

3

What is the impact of microvascular complications of diabetes on severe COVID-19?

enthalten in: Microvascular research | 2022

von Basra, R. | Whyte, M. | Karalliedde, J. | +1

4

Mortality Rate Associated with Diabetes: Outcomes From a General Practice Level Analysis in England Using the Royal College of General Practitioners (RCGP) Database Indicate Stability Over a 15 Year Period

enthalten in: Diabetes therapy | 2022

von Heald, A. | Stedman, M. | Robinson, A. | +9

5

Mortality Rate Associated with Diabetes: Outcomes From a General Practice Level Analysis in England Using the Royal College of General Practitioners (RCGP) Database Indicate Stability Over a 15 Year Period

enthalten in: Diabetes therapy | 2022

von Heald, A. | Stedman, M. | Robinson, A. | +9

6

Mortality Rate Associated with Diabetes: Outcomes From a General Practice Level Analysis in England Using the Royal College of General Practitioners (RCGP) Database Indicate Stability Over a 15 Year Period

enthalten in: Diabetes therapy | 2022

von Heald, A. | Stedman, M. | Robinson, A. | +9

7

The Effect of Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitors on Cardiometabolic Profile; Beyond the Hypoglycaemic Action

enthalten in: Cardiovascular drugs and therapy | 2017

von Lioudaki, E. | Androulakis, E. | Whyte, M. | +3

8

The Effect of Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitors on Cardiometabolic Profile; Beyond the Hypoglycaemic Action

enthalten in: Cardiovascular drugs and therapy | 2017

von Lioudaki, E. | Androulakis, E. | Whyte, M. | +3

9

The Effect of Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitors on Cardiometabolic Profile; Beyond the Hypoglycaemic Action

enthalten in: Cardiovascular drugs and therapy | 2017

von Lioudaki, E. | Androulakis, E. | Whyte, M. | +3

10

The Effect of Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitors on Cardiometabolic Profile; Beyond the Hypoglycaemic Action

enthalten in: Cardiovascular drugs and therapy | 2017

von Lioudaki, E. | Androulakis, E. | Whyte, M. | +3

1
[1]